Carcinomes épidermoïdes multiples après traitement par ingénol mébutate
- 13 September 2019
- journal article
- letter
- Published by Elsevier BV in Annales de Dermatologie et de Vénéréologie
- Vol. 146 (12), 823-825
- https://doi.org/10.1016/j.annder.2019.08.005
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Carcinome épidermoïde de croissance rapide après traitement par mébutate d’ingénolAnnales de Dermatologie et de Vénéréologie, 2018
- Au-delà des kératoses actiniques, le champ de cancérisation cutanéAnnales de Dermatologie et de Vénéréologie, 2018
- Rapidly-growing squamous cell carcinoma shortly after treatment with ingenol mebutate for actinic keratoses: report of two casesBritish Journal of Dermatology, 2015
- Safety and tolerability of ingenol mebutate in the treatment of actinic keratosisExpert Opinion on Drug Safety, 2015
- Actinic Keratosis: Rationale and ManagementDermatology and Therapy, 2014
- Pharmacotherapeutic Management of Actinic Keratosis: Focus on Newer Topical AgentsAmerican Journal of Clinical Dermatology, 2013
- From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinomaJCI Insight, 2012
- Actinic keratosesCancer, 2009
- PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: Results of a randomized, double‐blind, vehicle‐controlled, multicentre, phase IIa studyAustralasian Journal of Dermatology, 2009
- Malignant Potential of Actinic Keratoses and the Controversy Over TreatmentArchives of Dermatology, 1991